Sudden cardiac death and obesity

Expert Review of Cardiovascular Therapy

Volumn 12, Issue 9, 2014, Pages 1099-1110

  Plourde, Benoit ^a,b   Sarrazin, Jean François ^a,b   Nault, Isabelle ^a,b   Poirier, Paul ^b,c  

^a Faculty of Medicine   (Canada)

^b LAVAL UNIVERSITY   (Canada)

^c Faculty of Pharmacy   (Canada)

Author keywords

autonomic nervous system; KATP channel; obesity; QT interval; RAAS; sudden cardiac death

Indexed keywords

EPLERENONE;

CARDIOMETABOLIC RISK; CARDIOMYOPATHY; COMORBIDITY; DIABETES MELLITUS; DISEASE ASSOCIATION; HEART LEFT VENTRICLE HYPERTROPHY; HEART RATE VARIABILITY; HEART VENTRICLE EXTRASYSTOLE; HUMAN; HYPERTENSION; IMPLANTABLE CARDIOVERTER DEFIBRILLATOR; METABOLIC SYNDROME X; NONHUMAN; OBESITY; PATHOLOGICAL ANATOMY; QT INTERVAL; QT PROLONGATION; RESUSCITATION; REVIEW; SLEEP DISORDERED BREATHING; SUDDEN CARDIAC DEATH; ANIMAL; CARDIOVASCULAR DISEASES; COMPLICATION; DEATH, SUDDEN, CARDIAC; OUT-OF-HOSPITAL CARDIAC ARREST; PREVALENCE; RISK FACTOR;

ANIMALS; CARDIOVASCULAR DISEASES; DEATH, SUDDEN, CARDIAC; HUMANS; OBESITY; OUT-OF-HOSPITAL CARDIAC ARREST; PREVALENCE; RISK FACTORS;

EID: 84906765897     PISSN: 14779072     EISSN: 17448344     Source Type: Journal    
DOI: 10.1586/14779072.2014.952283     Document Type: Review

References (110)

1. Zipes DP, Camm AJ, Borggrefe M, et al ACC/AHA/ESC 2006 guidelines for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death: A report of the American College of Cardiology/American Heart Association Task Force and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Develop guidelines for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death) developed in collaboration with the European Heart Rhythm Association and the Heart Rhythm Society. Europace 2006; 8(9):746-837
2. Huikuri HV, Castellanos A, Myerburg RJ. Sudden death due to cardiac arrhythmias. N Engl J Med 2001;345(20):1473-82
3. Noheria A, Teodorescu C, Uy-Evanado A, et al. Distinctive profile of sudden cardiac arrest in middle-Aged vs. older adults: A community-based study. Int J Cardiol 2013;168(4):3495-9
4. Hookana E, Junttila MJ, Puurunen VP, et al. Causes of nonischemic sudden cardiac death in the current era. Heart Rhythm 2011;8(10):1570-5
5. Hubert HB, Feinleib M, McNamara PM, Castelli WP. Obesity as an independent risk factor for cardiovascular disease: A 26-year follow-up of participants in the Framingham Heart Study. Circulation 1983;67(5):968-77
6. Pietrasik G, Goldenberg I, McNitt S, et al. Obesity as a risk factor for sustained ventricular tachyarrhythmias in MADIT II patients. J Cardiovasc Electrophysiol 2007; 18(2):181-4
7. Jensen MD, Ryan DH, Apovian CM, et al. 2013 AHA/ACC/TOS guideline for the management of overweight and obesity in adults: A report of the American college of cardiology/American heart association task force on practice guidelines and the obesity society. J Am Coll Cardiol 2014;63: 2985-3023
8. WHO. Global Health Observatory (GHO): Obesity 2008. WHO; Geneva, Switzerland: 2014
9. Ogden CL, Carroll MD, Kit BK, Flegal KM. Prevalence of childhood and adult obesity in the United States, 2011-2012. JAMA 2014;311(8):806-14
10. Bastien M, Poirier P, Lemieux I, Despres JP. Overview of epidemiology and contribution of obesity to cardiovascular disease. Prog Cardiovasc Dis 2014;56(4): 369-81
11. Finkelstein EA, Trogdon JG, Cohen JW, Dietz W. Annual medical spending attributable to obesity: Payer-And servicespecific estimates. Health Aff (Millwood) 2009;28(5):w822-31
12. Stecker EC, Reinier K, Marijon E, et al. Public health burden of sudden cardiac death in the United States. Circ Arrhythm Electrophysiol 2014;7(2):212-17
13. Ghoorah K, Campbell P, Kent A, et al. Obesity and cardiovascular outcomes: A review. Eur Heart J Acute Cardiovasc Care 2014. [Epub ahead of print]
14. Lavie CJ, Milani RV, Ventura HO. Obesity and cardiovascular disease: Risk factor, paradox, and impact of weight loss. J Am Coll Cardiol 2009;53(21):1925-32
15. Mottillo S, Filion KB, Genest J, et al. The metabolic syndrome and cardiovascular risk a systematic review and meta-Analysis. J Am Coll Cardiol 2010;56(14):1113-32
16. Clark AL, Fonarow GC, Horwich TB. Obesity and the obesity paradox in heart failure. Prog Cardiovasc Dis 2014;56(4): 409-14
17. Cornier MA, Despres JP, Davis N, et al. Assessing adiposity: A scientific statement from the american heart association. Circulation 2011;124(18):1996- 2019
18. Despres JP. Body fat distribution and risk of cardiovascular disease: An update. Circulation 2012;126(10):1301-13
19. Testori C, Sterz F, Losert H, et al. Cardiac arrest survivors with moderate elevated body mass index may have a better neurological outcome: A cohort study. Resuscitation 2011;82(7):869-73
20. De LE, Cote J, Gilbert G, et al. Visceral/ epicardial adiposity in nonobese and apparently healthy young adults: Association with the cardiometabolic profile. Atherosclerosis 2014;234(1):23-9
21. Demerath EW, Reed D, Rogers N, et al. Visceral adiposity and its anatomical distribution as predictors of the metabolic syndrome and cardiometabolic risk factor levels. Am J Clin Nutr 2008;88(5):1263-71
22. Kunita E, Yamamoto H, Kitagawa T, et al. Prognostic value of coronary artery calcium and epicardial adipose tissue assessed by non-contrast cardiac computed tomography. Atherosclerosis 2014;233(2):447-53
23. Neel JV. Diabetes mellitus: A 'thrifty' genotype rendered detrimental by 'progress'?. Am J Hum Genet 1962;14:353-62
24. Poirier P, Giles TD, Bray GA, et al. Obesity and cardiovascular disease: Pathophysiology. evaluation, and effect of weight loss: An update of the 1997 American Heart Association Scientific Statement on Obesity and Heart Disease from the Obesity Committee of the Council on Nutrition, Physical Activity, and Metabolism. Circulation 2006;113(6): 898-918
25. Britton KA, Fox CS. Ectopic fat depots and cardiovascular disease. Circulation 2011; 124(24):e837-41
26. Bedford E. The story of fatty heart. A disease of Victorian times. Br Heart J 1972;34(1):23-8
27. Amad KH, Brennan JC, Alexander JK. The cardiac pathology of chronic exogenous obesity. Circulation 1965;32(5):740-5
28. Alpert MA, Omran J, Mehra A, Ardhanari S. Impact of obesity and weight loss on cardiac performance and morphology in adults. Prog Cardiovasc Dis 2014;56(4):391-400
29. Wong C, Marwick TH. Obesity cardiomyopathy: Pathogenesis and pathophysiology. Nat Clin Pract Cardiovasc Med 2007;4(8):436-43
30. Harmancey R, Wilson CR, Taegtmeyer H. Adaptation and maladaptation of the heart in obesity. Hypertension 2008;52(2):181-7
31. Abel ED, Litwin SE, Sweeney G. Cardiac remodeling in obesity. Physiol Rev 2008; 88(2):389-419
32. Alpert MA. Obesity cardiomyopathy: Pathophysiology and evolution of the clinical syndrome. Am J Med Sci 2001; 321(4):225-36
33. Gautron L, Elmquist JK. Sixteen years and counting: An update on leptin in energy balance. J Clin Invest 2011;121(6):2087-93
34. Ilkun O, Boudina S. Cardiac dysfunction and oxidative stress in the metabolic syndrome: An update on antioxidant therapies. Curr Pharm Des 2013;19(27): 4806-17
35. Ouchi N, Shibata R, Walsh K. Cardioprotection by adiponectin. Trends Cardiovasc Med 2006;16(5):141-6
36. Shibata R, Ouchi N, Ito M, et al. Adiponectin-mediated modulation of hypertrophic signals in the heart. Nat Med 2004;10(12):1384-9
37. Ouchi N, Kihara S, Funahashi T, et al. Obesity, adiponectin and vascular inflammatory disease. Curr Opin Lipidol 2003;14(6):561-6
38. Giacchetti G, Faloia E, Mariniello B, et al. Overexpression of the renin-Angiotensin system in human visceral adipose tissue in normal and overweight subjects. Am J Hypertens 2002;15(5):381-8
39. Diez J. Effects of aldosterone on the heart: Beyond systemic hemodynamics?. Hypertension 2008;52(3):462-4
40. Messaoudi S, Jaisser F. Aldosterone and the mineralocorticoid receptor. Eur Heart J 2011;13(Suppl B):B4-9
41. Pitt B, Zannad F, Remme WJ, et al. The effect of spironolactone on morbidity and mortality in patients with severe heart failure. Randomized Aldactone Evaluation Study Investigators. N Engl J Med 1999; 341(10):709-17
42. Guo C, Ricchiuti V, Lian BQ, et al. Mineralocorticoid receptor blockade reverses obesity-related changes in expression of adiponectin, peroxisome proliferator-Activated receptor-gamma, and proinflammatory adipokines. Circulation 2008;117(17):2253-61
43. Thakur V, Richards R, Reisin E. Obesity, hypertension, and the heart. Am J Med Sci 2001;321(4):242-8
44. Tavora F, Zhang Y, Zhang M, et al. Cardiomegaly is a common arrhythmogenic substrate in adult sudden cardiac deaths, and is associated with obesity. Pathology 2012;44(3):187-91
45. Patel DA, Lavie CJ, Artham SM, et al. Effects of left ventricular geometry and obesity on mortality in women with normal ejection fraction. Am J Cardiol 2014; 113(5):877-80
46. Lavie CJ, Milani RV, Ventura HO, et al. Disparate effects of left ventricular geometry and obesity on mortality in patients with preserved left ventricular ejection fraction. Am J Cardiol 2007; 100(9):1460-4
47. Duflou J, Virmani R, Rabin I, et al. Sudden death as a result of heart disease in morbid obesity. Am Heart J 1995;130(2): 306-13
48. Lee V, Hemingway H, Harb R, et al. The prognostic significance of premature ventricular complexes in adults without clinically apparent heart disease: A meta-Analysis and systematic review. Heart 2012;98(17):1290-8
49. Ataklte F, Erqou S, Laukkanen J, Kaptoge S. Meta-Analysis of ventricular premature complexes and their relation to cardiac mortality in general populations. Am J Cardiol 2013;112(8): 1263-70
50. Chen T, Koene R, Benditt DG, Lu F. Ventricular ectopy in patients with left ventricular dysfunction: Should it be treated?. J Card Fail 2013;19(1):40-9
51. Nikolic G, Bishop RL, Singh JB. Sudden death recorded during Holter monitoring. Circulation 1982;66(1):218-25
52. Anthony R, Daubert JP, Zareba W, et al. Mechanisms of ventricular fibrillation initiation in MADIT II patients with implantable cardioverter defibrillators. Pacing Clin Electrophysiol 2008;31(2): 144-50
53. Messerli FH, Nunez BD, Ventura HO, Snyder DW. Overweight and sudden death. Increased ventricular ectopy in cardiopathy of obesity. Arch Intern Med 1987;147(10): 1725-8
54. Bikkina M, Larson MG, Levy D. Asymptomatic ventricular arrhythmias and mortality risk in subjects with left ventricular hypertrophy. J Am Coll Cardiol 1993;22(4):1111-16
55. Rautaharju PM, Surawicz B, Gettes LS, et al. AHA/ACCF/HRS recommendations for the standardization and interpretation of the electrocardiogram: Part IV: The ST segment, T and U waves, and the QT interval: A scientific statement from the American Heart Association Electrocardiography and Arrhythmias Committee, Council on Clinical Cardiology; the American College of Cardiology Foundation; and the Heart Rhythm Society. Endorsed by the International Society for Computerized Electrocardiology. J Am Coll Cardiol 2009; 53(11):982-91
56. Seyfeli E, Duru M, Kuvandik G, et al. Effect of obesity on P-wave dispersion and QT dispersion in women. Int J Obes (Lond) 2006;30(6):957-61
57. Mukerji R, Terry BE, Fresen JL, et al. Relation of left ventricular mass to QTc in normotensive severely obese patients. Obesity (Silver Spring) 2012;20(9):1950-4
58. Al-Salameh A, Allain J, Jacques A, et al. Shortening of the QT interval is observed soon after sleeve gastrectomy in morbidly obese patients. Obes Surg 2014;24(1): 167-70
59. Russo V, Ammendola E, De Crescenzo I, et al. Effect of weight loss following bariatric surgery on myocardial dispersion of repolarization in morbidly obese patients. Obes Surg 2007;17(7):857-65
60. Issa ZF, Miller JM, Zipes DP. Clinical arrhythmology and electrophysiology: A companion to Braunwald's heart disease. 2nd edition. 2012
61. Frank S, Colliver JA, Frank A. The electrocardiogram in obesity: Statistical analysis of 1,029 patients. J Am Coll Cardiol 1986;7(2):295-9
62. Arslan E, Yiginer O, Yavasoglu I, et al. Effect of uncomplicated obesity on QT interval in young men. Pol Arch Med Wewn 2010;120(6):209-13
63. Morrow JP. High-fat diet, obesity and sudden cardiac death. Acta Physiol (Oxf) 2014;211(1):13-16
64. Lin YC, Huang J, Kan H, et al. Defective calcium inactivation causes long QT in obese insulin-resistant rat. Am J Physiol Heart Circ Physiol 2012;302(4):H1013-22
65. Brayden JE. Functional roles of KATP channels in vascular smooth muscle. Clin Exp Pharmacol Physiol 2002;29(4):312-16
66. Hiriart M, Velasco M, Larque C, Diaz-Garcia CM. Metabolic syndrome and ionic channels in pancreatic beta cells. Vitam Horm 2014;95:87-114
67. Borbouse L, Dick GM, Payne GA, et al. Metabolic syndrome reduces the contribution of K+ channels to ischemic coronary vasodilation. Am J Physiol Heart Circ Physiol 2010;298(4):H1182-9
68. Aizawa Y, Uchiyama H, Yamaura M, et al. Effects of the ATP-sensitive K channel opener nicorandil on the QT interval and the effective refractory period in patients with congenital long QT syndrome. Investigator Group for K-Channel Openers and Arrhythmias. J Electrocardiol 1998; 31(2):117-23
69. Kobayashi Y, Yazawa T, Adachi T, et al. Ventricular arrhythmias with left bundle branch block pattern and inferior axis: Assessment of their mechanisms on the basis of response to ATP, nicorandil and verapamil. Jpn Circ J 2000;64(11):835-41
70. Biermann J, Wu K, Odening KE, et al. Nicorandil normalizes prolonged repolarisation in the first transgenic rabbit model with Long-QT syndrome 1 both in vitro and in vivo. Eur J Pharmacol 2011; 650(1):309-16
71. Testai L, Cecchetti V, Sabatini S, et al. Effects of K openers on the QT prolongation induced by HERG-blocking drugs in guinea-pigs. J Pharm Pharmacol 2010;62(7):924-30
72. Huang H, Amin V, Gurin M, et al. Diet-induced obesity causes long QT and reduces transcription of voltage-gated potassium channels. J Mol Cell Cardiol 2013;59:151-8
73. Goldberger JJ, Cain ME, Hohnloser SH, et al American Heart Association/American College of Cardiology Foundation/Heart Rhythm Society scientific statement on noninvasive risk stratification techniques for identifying patients at risk for sudden cardiac death: A scientific statement from the American Heart Association Council on Clinical Cardiology Committee on Electrocardiography and Arrhythmias and Council on Epidemiology and Prevention. Circulation 2008;118(14):1497-518
74. Masui A, Tsuji H, Tamura K, et al. Effect of body characteristics on the variables of signal-Averaged electrocardiograms in healthy subjects. Chest 1994;105(5):1357-9
75. Lalani AP, Kanna B, John J, et al. Abnormal signal-Averaged electrocardiogram (SAECG) in obesity. Obes Res 2000;8(1): 20-8
76. Drager LF, Lopes HF, Maki-Nunes C, et al. The impact of obstructive sleep apnea on metabolic and inflammatory markers in consecutive patients with metabolic syndrome. PLoS One 2010;5(8):e12065
77. Drager LF, Togeiro SM, Polotsky VY, Lorenzi-Filho G. Obstructive sleep apnea: A cardiometabolic risk in obesity and the metabolic syndrome. J Am Coll Cardiol 2013;62(7):569-76
78. Jordan AS, McSharry DG, Malhotra A. Adult obstructive sleep apnoea. Lancet 2014;383(9918):736-47
79. Peppard PE, Young T, Palta M, et al. Longitudinal study of moderate weight change and sleep-disordered breathing. JAMA 2000;284(23):3015-21
80. Gami AS, Howard DE, Olson EJ, Somers VK. Day-night pattern of sudden death in obstructive sleep apnea. N Engl J Med 2005;352(12):1206-14
81. Gami AS, Olson EJ, Shen WK, et al. Obstructive sleep apnea and the risk of sudden cardiac death: A longitudinal study of 10,701 adults. J Am Coll Cardiol 2013; 62(7):610-16
82. Paolisso G, Gualdiero P, Manzella D, et al. Association of fasting plasma free fatty acid concentration and frequency of ventricular premature complexes in nonischemic non-insulin-dependent diabetic patients. Am J Cardiol 1997;80(7):932-7
83. Bombelli M, Facchetti R, Sega R, et al. Impact of body mass index and waist circumference on the long-Term risk of diabetes mellitus, hypertension, and cardiac organ damage. Hypertension 2011;58(6): 1029-35
84. Laukkanen JA, Makikallio TH, Ronkainen K, et al. Impaired fasting plasma glucose and type 2 diabetes are related to the risk of out-of-hospital sudden cardiac death and all-cause mortality. Diabetes Care 2013;36(5):1166-71
85. Kuperstein R, Hanly P, Niroumand M, Sasson Z. The importance of age and obesity on the relation between diabetes and left ventricular mass. J Am Coll Cardiol 2001;37(7):1957-62
86. Madala MC, Franklin BA, Chen AY, et al. Obesity and age of first non-ST-segment elevation myocardial infarction. J Am Coll Cardiol 2008;52(12):979-85
87. Srinivasan V, Nadkarni VM, Helfaer MA, et al. Childhood obesity and survival after in-hospital pediatric cardiopulmonary resuscitation. Pediatrics 2010;125(3):e481-8
88. Bunch TJ, White RD, Lopez-Jimenez F, Thomas RJ. Association of body weight with total mortality and with ICD shocks among survivors of ventricular fibrillation in out-of-hospital cardiac arrest. Resuscitation 2008;77(3):351-5
89. White RD, Blackwell TH, Russell JK, Jorgenson DB. Body weight does not affect defibrillation, resuscitation, or survival in patients with out-of-hospital cardiac arrest treated with a nonescalating biphasic waveform defibrillator. Crit Care Med 2004;32(9 Suppl):S387-92
90. Venkataraman G, Mathur D, Joshi S, Strickberger A. Comparison of ICD implantation in obese and nonobese patients. Pacing Clin Electrophysiol 2014; 37(4):481-5
91. Hsu JC, Varosy PD, Bao H, et al. Low body mass index but not obesity is associated with in-hospital adverse events and mortality among implantable cardioverter-defibrillator recipients: Insights from the National Cardiovascular Data Registry. J Am Heart Assoc 2012;1(6): E003863
92. Gandhi M, Koelling TM, Pelosi F Jr, et al. Association of implantable defibrillator therapy risk with body mass index in systolic heart failure. Heart Lung 2013; 42(4):257-61
93. Choy B, Hansen E, Moss AJ, et al. Relation of body mass index to sudden cardiac death and the benefit of implantable cardioverter-defibrillator in patients with left ventricular dysfunction after healing of myocardial infarction. Am J Cardiol 2010; 105(5):581-6
94. Lambiase PD, Barr C, Theuns DA, et al. Worldwide experience with a totally subcutaneous implantable defibrillator: Early results from the EFFORTLESS S-ICD Registry. Eur Heart J 2014;35(25):1657-65
95. Olde Nordkamp LR, Dabiri AL, Boersma LV, et al. The entirely subcutaneous implantable cardioverterdefibrillator: Initial clinical experience in a large Dutch cohort. J Am Coll Cardiol 2012;60(19):1933-9
96. Jarman JW, Lascelles K, Wong T, et al. Clinical experience of entirely subcutaneous implantable cardioverter-defibrillators in children and adults: Cause for caution. Eur Heart J 2012;33(11):1351-9
97. Ades PA, Savage PD. Potential benefits of weight loss in coronary heart disease. Prog Cardiovasc Dis 2014;56(4):448-56
98. Poirier P, Auclair A. Role of bariatric surgery in diabetes. Curr Cardiol Rep 2014; 16(2):444
99. Swift DL, Johannsen NM, Lavie CJ, et al. The role of exercise and physical activity in weight loss and maintenance. Prog Cardiovasc Dis 2014;56(4):441-7
100. Sjostrom L, Narbro K, Sjostrom CD, et al. Effects of bariatric surgery on mortality in Swedish obese subjects. N Engl J Med 2007;357(8):741-52
101. Gondoni LA, Titon AM, Montano M, et al. The myth of QT shortening by weight loss and physical training in obese subjects with coronary heart disease. Obesity (Silver Spring) 2011;19(1):200-3
102. Kodama S, Saito K, Tanaka S, et al. Cardiorespiratory fitness as a quantitative predictor of all-cause mortality and cardiovascular events in healthy men and women: A meta-Analysis. JAMA 2009; 301(19):2024-35
103. Barry VW, Baruth M, Beets MW, et al. Fitness vs. fatness on all-cause mortality: A meta-Analysis. Prog Cardiovasc Dis 2014; 56(4):382-90
104. Lavie CJ, McAuley PA, Church TS, et al. Obesity and cardiovascular diseases: Implications regarding fitness, fatness, and severity in the obesity paradox. J Am Coll Cardiol 2014;63(14):1345-54
105. McAuley PA, Beavers KM. Contribution of cardiorespiratory fitness to the obesity paradox. Prog Cardiovasc Dis 2014;56(4): 434-40
106. Dangardt FJ, McKenna WJ, Luscher TF, Deanfield JE. Exercise: Friend or foe?. Nat Rev Cardiol 2013;10(9):495-507
107. Franklin BA, Lavie CJ. Triggers of acute cardiovascular events and potential preventive strategies: Prophylactic role of regular exercise. Phys Sportsmed 2011; 39(4):11-21
108. Poirier P, Alpert MA, Fleisher LA, et al. Cardiovascular evaluation and management of severely obese patients undergoing surgery: A science advisory from the American Heart Association. Circulation 2009;120(1):86-95
109. Gibbons RJ, Balady GJ, Beasley JW, et al. ACC/AHA guidelines for exercise testing: Executive summary. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on Exercise Testing). Circulation 1997;96(1): 345-54
110. Poirier P, Despres JP. Exercise in weight management of obesity. Cardiol Clin 2001; 19(3):459-70.